722550-01-8

Basic information

• Product Name: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)
• Synonyms: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI);2-Amino-4-pyrrolidinopyridine;2-Amino-4-(pyrrolidin-1-yl)pyridine;4-(Pyrrolidin-1-yl)pyridin-2-amine, 1-(2-Aminopyridin-4-yl)pyrrolidine;4-(1-pyrrolidinyl)-2-Pyridinamine
• CAS NO: 722550-01-8
• Molecular Formula: C₉H₁₃N₃
• Molecular Weight: 163.223
• Product Categories: AMINETERTIARY
• Mol File: 722550-01-8.mol

Chemical Properties

• Boiling Point: 353.005°C at 760 mmHg
• Flash Point: 167.292°C
• Appearance: /
• Density: 1.17g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.617
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(722550-01-8)
• EPA Substance Registry System: 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI)(722550-01-8)

Safety Data

• Hazardous Substances Data: 722550-01-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI) is used as an intermediate in the synthesis of various drugs for medical purposes. Its unique structure allows it to be a key component in the development of pharmaceuticals that target a range of health conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI) is utilized as a versatile building block for the creation of new organic compounds. Its presence in chemical reactions can lead to the formation of a variety of products with different applications.
Used in Research and Development:
2-Pyridinamine,4-(1-pyrrolidinyl)-(9CI) is also employed in research and development settings, where it is used to explore new chemical reactions and investigate its potential applications in creating novel drug candidates and other organic compounds. Its aromatic nature and the presence of the pyrrolidine ring make it a promising candidate for further exploration and innovation in the chemical and pharmaceutical industries.

InChI:InChI=1/C9H13N3/c10-9-7-8(3-4-11-9)12-5-1-2-6-12/h3-4,7H,1-2,5-6H2,(H2,10,11)

Upstream product

• 123-75-1 pyrrolidine 
• 19798-80-2 2-Amino-4-chloropyridine 

Relevant articles and documents

Synthesis of 2,5-thiazole butanoic acids as potent and selective αvβ3 integrin receptor antagonists with improved oral pharmacokinetic properties

We describe a series of 2,5 thiazole containing compounds, which are potent antagonists of the integrin αvβ3 and show selectivity relative to the other integrins, such as αIIbβ 3 and αvβ6. These analogs were demonstrated to have high bioavailability relative to other relative heterocyclic analogs.

QUINAZOLINE DERIVATIVES

The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.

THIAZOLE COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES

The present invention relates to pharmaceutical compositions comprising compounds of the Formula (I), and methods of selectively inhibiting or antagonizing the ανβ3 and/or the ανβ5 integrin without significantly inhibiting the ανβ6 integrin.